109 related articles for article (PubMed ID: 19695901)
1. Effects of hepatic artery chemoembolization using cisplatin-lipiodol suspension with gelatin sponge particles on swine liver.
Sahara S; Tanihata H; Sato M; Kawai N; Takasaka I; Minamiguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2009 Oct; 20(10):1359-64. PubMed ID: 19695901
[TBL] [Abstract][Full Text] [Related]
2. Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for hepatocellular carcinoma.
Maeda S; Shibata J; Fujiyama S; Tanaka M; Noumaru S; Sato K; Tomita K
Hepatogastroenterology; 2003; 50(51):809-13. PubMed ID: 12828090
[TBL] [Abstract][Full Text] [Related]
3. Tissue tolerance to pelvic intraarterial chemoembolization with cisplatin-lipiodol suspension.
Li J; Zhao YN; Miao ZJ; Zhu L; Wang ZM; Qin HY; Xi JH
Gynecol Oncol; 1993 Jul; 50(1):10-4. PubMed ID: 8394274
[TBL] [Abstract][Full Text] [Related]
4. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
[TBL] [Abstract][Full Text] [Related]
5. [Effects of experimental hepatic artery embolization with lipiodol and gelatin sponge on liver tissue].
Sato M; Kishi K; Shioyama Y; Tsuda M; Terada M; Tanaka H; Nakatani K; Sonomura T; Maeda M; Daimon M
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Feb; 50(2):107-13. PubMed ID: 2163519
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of hepatic arterial embolization on radiofrequency ablation volume in a swine model: relationship to portal venous flow and liver parenchymal pressure.
Iwamoto T; Kawai N; Sato M; Tanihata H; Takasaka I; Minamiguchi H; Sahara S; Nakata K; Shirai S
J Vasc Interv Radiol; 2008 Nov; 19(11):1646-51. PubMed ID: 18954767
[TBL] [Abstract][Full Text] [Related]
7. Lipiodolization with or without gelatin sponge in hepatic arterial chemoembolization for hepatocellular carcinoma.
Lu CD; Qi YG; Peng SY
Chin Med J (Engl); 1994 Mar; 107(3):209-15. PubMed ID: 8088182
[TBL] [Abstract][Full Text] [Related]
8. [Tissue tolerance to pelvic intraarterial chemoembolization].
Li J
Zhonghua Fu Chan Ke Za Zhi; 1993 Jan; 28(1):41-3, 61. PubMed ID: 8389277
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the role of cisplatin-conjugated-soluble gelatin sponge: feasibility study in a swine model.
Ikoma A; Kawai N; Sato M; Minamiguchi H; Nakata K; Nakai M; Sanda H; Sonomura T; Kanayama Y; Sakai Y
Cardiovasc Intervent Radiol; 2013 Aug; 36(4):1097-104. PubMed ID: 23073562
[TBL] [Abstract][Full Text] [Related]
10. Extension of radiofrequency ablation of the liver by transcatheter arterial embolization with iodized oil and gelatin sponge: results in a pig model.
Sugimori K; Nozawa A; Morimoto M; Shirato K; Kokawa A; Saito T; Numata K; Tanaka K
J Vasc Interv Radiol; 2005 Jun; 16(6):849-56. PubMed ID: 15947049
[TBL] [Abstract][Full Text] [Related]
11. Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver.
Sato M; Yamada R; Uchida B; Hedgepeth P; Rosch J
Cardiovasc Intervent Radiol; 1993; 16(6):348-54. PubMed ID: 8131165
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of transcatheter arterial chemoembolization with 2-day-soluble gelatin sponge particles for hepatocellular carcinoma-comparison with insoluble gelatin sponge particles.
Kawai N; Sato M; Minamiguchi H; Ikoma A; Sanda H; Nakata K; Sato H; Sakaguchi H; Nakai M; Sonomura T
J Vasc Interv Radiol; 2013 Sep; 24(9):1383-90. PubMed ID: 23727419
[TBL] [Abstract][Full Text] [Related]
13. Suitable blending method of lipiodol-cisplatin in transcatheter arterial embolization for hepatocellular carcinoma: evaluation of sustained release and accumulation nature.
Takaki Y; Kaminou T; Shabana M; Ihaya T; Otsubo K; Ogawa T
Hepatogastroenterology; 2008; 55(81):202-6. PubMed ID: 18507107
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation combined with reduction of hepatic blood flow: effect of Lipiodol on coagulation diameter and ablation time in normal pig liver.
Chung H; Kudo M; Minami Y; Kawasaki T
Hepatogastroenterology; 2007; 54(75):701-4. PubMed ID: 17591045
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma.
Lo CM; Ngan H; Tso WK; Liu CL; Lam CM; Poon RT; Fan ST; Wong J
Hepatology; 2002 May; 35(5):1164-71. PubMed ID: 11981766
[TBL] [Abstract][Full Text] [Related]
16. [Chemoembolization therapy with cisplatin.lipiodol (CDDP.lipiodol) in primary liver cancer--with special reference to hepatocellular carcinoma].
Yodono H; Tarusawa K; Kanehira J; Fukuda E; Ikami I; Sakaki T; Kamata K; Sasaki D; Sasaki M
Gan To Kagaku Ryoho; 1986 Dec; 13(12):3476-82. PubMed ID: 3024580
[TBL] [Abstract][Full Text] [Related]
17. [Interventional therapy of hepatic artery-portal vein fistula with gelatin sponge and lipiodol].
Xu HF; Yang RJ; Chen H; Zhu X
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(15):1061-3. PubMed ID: 21609644
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization using cisplatin powder in a rabbit model of liver cancer.
Morimoto K; Sakaguchi H; Tanaka T; Yamamoto K; Anai H; Hayashi T; Satake M; Kichikawa K
Cardiovasc Intervent Radiol; 2008; 31(5):981-5. PubMed ID: 18535857
[TBL] [Abstract][Full Text] [Related]
19. Indication of chemoembolization therapy without gelatin sponge for hepatocellular carcinoma.
Suzuki M; Suzuki H; Yamamoto T; Mamada Y; Mizuno H; Tominaga T; Suga M; Suemori S; Kato Y; Sato A; Yamanouchi E; Sakuyama K; Maeyama S; Shinagawa T; Okabe K
Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-110-S6-115. PubMed ID: 9151925
[TBL] [Abstract][Full Text] [Related]
20. [Effect of the portal vein injection of cisplatin and lipiodol on rat liver].
Ono Y; Yoshioka H; Kawakami A; Ishida O; Suzuki T
Gan To Kagaku Ryoho; 1989 Oct; 16(10):3429-34. PubMed ID: 2552932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
